These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7974913)

  • 1. The effect of active immunization against gonadotropin-releasing hormone on the ultrastructure of the rat ventral prostate.
    Fürst J; Fiebiger E; Mack D; Frick J; Rovan E
    Urol Res; 1994; 22(2):107-13. PubMed ID: 7974913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic gonadotrophin-releasing hormone (GnRH) vaccines incorporating GnRH and synthetic T-helper epitopes.
    Sad S; Chauhan VS; Arunan K; Raghupathy R
    Vaccine; 1993; 11(11):1145-50. PubMed ID: 7504380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of active immunization to luteinizing-hormone-releasing hormone on the fertility and histoarchitecture of the reproductive organs of male rat.
    Rovan E; Fiebiger E; Kalla NR; Talwar GP; Aulitzky W; Frick J
    Urol Res; 1992; 20(5):323-34. PubMed ID: 1455565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for control of fertility and hormone dependent cancers.
    Talwar GP; Singh O; Pal R; Chatterjee N
    Int J Immunopharmacol; 1992 Apr; 14(3):511-4. PubMed ID: 1618603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A vaccination strategy for the long-term suppression of androgens in advanced prostate cancer.
    Parkinson RJ; Simms MS; Broome P; Humphreys JE; Bishop MC
    Eur Urol; 2004 Feb; 45(2):171-4; discussion 174-5. PubMed ID: 14734002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bypass of carrier-induced epitope-specific suppression using a T-helper epitope.
    Sad S; Rao K; Arora R; Talwar GP; Raghupathy R
    Immunology; 1992 Aug; 76(4):599-603. PubMed ID: 1383134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the genetic background and carrier protein on the antibody response to GnRH.
    Sad S; Talwar GP; Raghupathy R
    J Reprod Immunol; 1991 Feb; 19(2):197-207. PubMed ID: 2008003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocontraceptive Effects in Male Rats Vaccinated with Gonadotropin-Releasing Hormone-I and -II Protein Complex.
    Kim YH; Park BJ; Ahn HS; Han SH; Go HJ; Lee JB; Park SY; Song CS; Lee SW; Choi IS
    J Microbiol Biotechnol; 2019 Apr; 29(4):658-664. PubMed ID: 30845792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier-induced suppression of the antibody response to a 'self' hapten.
    Sad S; Gupta HM; Talwar GP; Raghupathy R
    Immunology; 1991 Oct; 74(2):223-7. PubMed ID: 1748470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active immunization with GnRH-tandem-dimer peptide in young male rats reduces serum reproductive hormone concentrations, testicular development and spermatogenesis.
    Han XF; Li JL; Zhou YQ; Ren XH; Liu GC; Cao XH; Du XG; Zeng XY
    Asian J Androl; 2016; 18(3):485-91. PubMed ID: 26208395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active immunization against GnRH reduces the synthesis of GnRH in male rats.
    Han XF; Cao XH; Tang J; Du XG; Zeng XY
    Theriogenology; 2013 Dec; 80(9):1109-16. PubMed ID: 24084232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation into suitable carrier molecules for use in an anti-gonadotrophin releasing hormone vaccine.
    Ferro VA; Stimson WH
    Vaccine; 1998 Jul; 16(11-12):1095-102. PubMed ID: 9682364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyporesponsiveness to a GnRH vaccine in a non-responder mouse strain is T-cell mediated.
    Sad S; Gupta HM; Talwar GP; Raghupathy R
    J Reprod Immunol; 1991 Jul; 20(2):189-94. PubMed ID: 1753388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The compensatory expression of reproductive hormone receptors in the thymus of the male rat following active immunization against GnRH.
    Su S; Fang F; Liu Y; Li Y; Ren C; Zhang Y; Zhang X
    Gen Comp Endocrinol; 2013 May; 185():57-66. PubMed ID: 23395683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of two GnRH-I based vaccine formulations on the testes function of entire Suffolk cross ram lambs.
    Earl ER; Waterston MM; Aughey E; Harvey MJ; Matschke C; Colston A; Ferro VA
    Vaccine; 2006 Apr; 24(16):3172-83. PubMed ID: 16483697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoneutralisation of GnRH-I, without cross-reactivity to GnRH-II, in the development of a highly specific anti-fertility vaccine for clinical and veterinary use.
    Ferro VA; Khan MA; Latimer VS; Brown D; Urbanski HF; Stimson WH
    J Reprod Immunol; 2001 Aug; 51(2):109-29. PubMed ID: 11543851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of docetaxel chemotherapy on the activity of a gonadotropin releasing hormone vaccine in patients with advanced prostate cancer.
    Triozzi PL; Bolger GB; Neidhart J; Rinehart JJ; Saleh M; Allen KO; Sellers S; Waddell MJ
    Prostate; 2005 Dec; 65(4):316-21. PubMed ID: 16015596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of gonadotropin-releasing hormone vaccination on T lymphocyte changes in male rats.
    Su S; Zhou X; Zhang X; Fang F
    J Reprod Immunol; 2017 Apr; 120():1-7. PubMed ID: 28196761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic toxicity and reversibility of antifertility effect of immunization against gonadotropin-releasing hormone in male rats and rabbits.
    Kumar N; Savage T; DeJesus W; Tsong YY; Didolkar A; Sundaram K
    Toxicol Sci; 2000 Jan; 53(1):92-9. PubMed ID: 10653526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer.
    Simms MS; Scholfield DP; Jacobs E; Michaeli D; Broome P; Humphreys JE; Bishop MC
    Br J Cancer; 2000 Aug; 83(4):443-6. PubMed ID: 10945488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.